Nano-Immunotherapy Accelerates Recovery of Patient with Covid-19: Clinical Analysis and Metabolomics

In a severe COVID-19 patient case (78-year old male) that was under active immunotherapy for high-grade non-muscle invasive bladder cancer was followed. He received a shorter hospitalization period, as hypothesis it was suggested that active immunotherapy played a crucial role together to anti-inflammatory and antiviral treatment in precluding the evolution of pulmonary symptoms to a poor prognosis.